Rheumatoid arthritis

Preview

Once considered relatively benign, rheumatoid arthritis is now recognized as a disabling systemic disease that causes substantial morbidity and mortality. Early, aggressive therapy may be critical for altering the course of disease. Drs Vikings-son and Graziano describe the causes and clinical course of rheumatoid arthritis and discuss diagnostic considerations and prognostic indicators that support optimum management.

Additional information

Notes on contributors

Arnor Vikingsson

Arnor Vikingsson, MD Frank M. Graziano, MD, PhD Dr Vikingsson (left) is a senior fellow in rheumatology, and Dr Graziano (right) is professor of medicine and chief, section of rheumatology, University of Wisconsin Medical School, Madison.

Frank M. Graziano

Arnor Vikingsson, MD Frank M. Graziano, MD, PhD Dr Vikingsson (left) is a senior fellow in rheumatology, and Dr Graziano (right) is professor of medicine and chief, section of rheumatology, University of Wisconsin Medical School, Madison.